Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer.

TheScientificWorldJournal - 1 Oct 2010

Tosoian Jeffrey, Loeb Stacy

Abstract excerpt

The discovery of prostate-specific antigen (PSA) as a biomarker represented a major discovery in the early diagnosis and monitoring of prostate cancer. However, the use of PSA is limited by the lack of specificity and an inability to differentiate indolent from life-threatening disease reliably at the time of diagnosis. A multitude of studies have aimed to improve the performance of PSA as well as identify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Forecasting
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Polymorphism, Single Nucleotide

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 20890581
DOI: 10.1100/tsw.2010.182
PMCID: PMC5763794

Genes

AMACR
GSTP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer.PMID 20890581Read ↗

Use and assessment of PSA in prostate cancer.Semantic proximity Read ↗

Molecular diagnosis of prostate cancer: are we up to age?Semantic proximity Read ↗

Prostate cancer – a biomarker perspectiveSemantic proximity Read ↗

Biomarkers in Localized Prostate Cancer: Towards a Personalized MedicineSemantic proximity Read ↗

Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identificationSemantic proximity Read ↗

[Markers for diagnosis, prediction and prognosis of prostate cancer].Semantic proximity Read ↗

The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsSemantic proximity Read ↗

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.Semantic proximity Read ↗

[Non-invasive diagnosis of prostate cancer: serum and urine markers].Semantic proximity Read ↗

Prostate Cancer Gene Expression Marker 1 (PCGEM1): A Patented Prostate- Specific Non-Coding Gene and Regulator of Prostate Cancer ProgressionSemantic proximity Read ↗

Diagnosis, staging, and risk stratification in prostate cancer: Utilizing diagnostic tools to avoid unnecessary therapies and side effects.Semantic proximity Read ↗

Prostate-specific antigen testing and prostate cancer screening.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.